Presentation of a medullary endocrine neoplasia 2A kindred with Cushing's syndrome

American Surgeon

Volumn 74, Issue 7, 2008, Pages 659-661

  Zaydfudim, Victor ^a   Stover, Daniel G ^a   Caro, Susan W ^b   Phay, John E ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FLUOROURACIL; KETOCONAZOLE; OCTREOTIDE; STREPTOZOCIN; TUMOR MARKER;

ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CLINICAL EVALUATION; CODON; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DYSPNEA; FACIES; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HIRSUTISM; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; HYPERCORTISOLISM; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LAPAROSCOPIC SURGERY; LIVER; LIVER METASTASIS; MEDULLARY ENDOCRINE NEOPLASIA 2A; MOON FACE; NEEDLE BIOPSY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PROTO ONCOGENE; STRIA; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; WEAKNESS; WEIGHT GAIN; ADRENAL TUMOR; BLOOD; DIFFERENTIAL DIAGNOSIS; LAPAROSCOPY; MEDULLARY CARCINOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SIPPLE SYNDROME; THYROID TUMOR;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; BIOPSY, FINE-NEEDLE; CARCINOMA, MEDULLARY; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LAPAROSCOPY; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 48549104827     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Cote GJ, Gagel RF. Lessons learned from the management of a rare genetic cancer. N Engl J Med 2003;349:1566-1568 (Pubitemid 37255043)
2. Shapiro SE, Cote GC, Lee JE, et al. The role of genetics in the surgical management of familial endocrinopathy syndromes. J Am Coll Surg 2003;197:818-831 (Pubitemid 38199586)
3. Phay JE, Moley JF, Lairmore TC. Multiple endocrine neoplasias. Semin Surg Oncol 2000;18:324-332 (Pubitemid 30253025)
4. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-5671 (Pubitemid 33152604)
5. Barbosa SL, Rodien P, Leboulleux S, et al. Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: A retrospective analysis and review of the literature. Thyroid 2005;15:618-623 (Pubitemid 40993738)
6. Meador CK, Liddle GW, Island DP, et al. Cause of Cushing's syndrome in patients with tumors arising from "nonendocrine" tissue. J Clin Endocrinol Metab 1962;22:693-703.
7. Smallridge RC, Bourne K, Pearson BW, et al. Cushing's syndrome due to medullary thyroid carcinoma: Diagnosis by pro-opiomelanocortin messenger ribonucleic acid in situ hybridization. J Clin Endocrinol Metab 2003;88:4565-4568 (Pubitemid 37357494)
8. Aniszewski JP, Young WF Jr, Thompson GB, et al. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg 2001;25:934-940 (Pubitemid 32666396)
9. Steiner AL, Goodman AD, Powers SR. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: Multiple endocrine neoplasia, type 2. Medicine (Baltimore) 1968;47:371-409.
10. Tagliabue M, Pagani A, Palestini N, et al. Multiple endocrine neoplasia (MEN IIB) with Cushing's syndrome due to medullary thyroid carcinoma producing corticotropin-releasing hormone. Panminerva Med 1996;38:41-44 (Pubitemid 126456557)